Company: FTII
Filing Date: 2025-01-31
Form Type: 8-K
Source: 0001493152-25-004420
Chunk: 0

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-01-31
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item
1.01 Entry into a Material Definitive Agreement.

Subscription
Agreement

On
December 13, 2024, FutureTech II Acquisition Corp. (the
“ Company, entered into a Subscription Agreement (the “Subscription
Agreement”) with Yuantian Zhang (the “Investor”), pursuant to which, among other things, the Investor agreed
to subscribe for and purchase, and the Company agreed to issue and sell to the Investor, 1,000,000 shares of the Company’s Class
A Common Stock, par value $0.0001 per share (the “Common Stock”), at a purchase price equal to $5.00 per share (the
“Private Placement”) in connection with a financing effort related to the proposed business combination (the “Business
Combination”) to be effected pursuant to the Agreement and Plan of Merger, dated as of September 16, 2024, as amended, by and
among the Company, Longevity Biomedical, Inc. (“Longevity”), a Delaware corporation, the Company, LBI Merger Sub,
Inc., a Delaware corporation and direct, wholly owned subsidiary of the Company, and Bradford A. Zakes, solely in the capacity as seller
representative (the “Merger Agreement”). The effectiveness of the Subscription Agreement is conditioned upon entering
into an escrow agreement between the Company and the Investor. In addition, the closing (the “Closing”) of the Private
Placement is contingent upon the concurrent consummation of the Business Combination.

On
January 31, 2025, in connection with the Subscription Agreement, the Company and the Investor signed an
escrow agreement dated January 23, 2025 (the “ Escrow Agreement Escrow Shares Escrow Property Escrow Release Date and only if all
shares of Common Stock issued to the Investor at or before the Closing plus the value of the portion of provided however provided further

The
foregoing descriptions of the Subscription Agreement, the Escrow Agreement and the transactions contemplated thereby are only summaries
and do not purport to be complete, and are qualified in their entirety by reference to the full text of such instruments, a copy of which
is attached to this Current Report on Form 8-K as Exhibit 10.1 and Exhibit 10.2, respectively, and incorporated herein by reference.

Item
9.01 Financial Statements and Exhibits.